Orsense, Ltd.
OrSense is a medical device company developing and marketing non-invasive monitoring systems for measurement of hemoglobin, oxygen saturation, glucose, and other blood parameters. Their proprietary Occlusion Spectroscopy technology enables accurate, safe, and non-invasive blood parameter measurements. Their products are FDA and CE approved, available in numerous countries, and are installed in hospitals, blood donation centers, clinics, and for various health applications worldwide. The company's mission is to improve blood monitoring through innovative, non-invasive solutions, enhancing donor and patient comfort, safety, and operational efficiency.
Industries
Nr. of Employees
small (1-50)
Orsense, Ltd.
6 Ha’Nechoshet Street, Tel Aviv-Yafo, 6971070, Israel
Patents
Products
Non-invasive hemoglobin and oximetry monitor (ring-sensor device)
Portable device that uses a ring-shaped finger sensor and occlusion-based optical measurement to provide non-invasive hemoglobin, oxygen saturation and pulse rate readings for spot and continuous use.
Non-invasive hemoglobin and oximetry monitor (ring-sensor device)
Portable device that uses a ring-shaped finger sensor and occlusion-based optical measurement to provide non-invasive hemoglobin, oxygen saturation and pulse rate readings for spot and continuous use.
Services
Cloud platform for managing device inventories and shortening delivery cycles from supplier to client and from inventory to field deployment.
Cloud platform for managing device inventories and shortening delivery cycles from supplier to client and from inventory to field deployment.
Expertise Areas
- Non-invasive hemoglobin monitoring
- Continuous patient monitoring
- Point-of-care diagnostics
- Clinical validation and multi-site trials
Key Technologies
- Occlusion spectroscopy (occlusion-based optical transmission)
- Optical transmission spectroscopy
- Ring-shaped pneumatic finger sensor
- Continuous hemoglobin monitoring
News & Updates
The Red Cross has a new prick-free method to test hemoglobin levels, improving donor experience.
Hoxworth Blood Center adopted OrSense’s NBM-200 device to enhance donor comfort by eliminating finger pricks.
Cedars-Sinai Blood Donor Services implemented OrSense’s NBM-200 device to replace traditional finger pricks.
The blood bank utilizes OrSense’s NBM-200 device to streamline donations and reduce discomfort.
LifeServe Blood Center introduces OrSense’s NBM-200 for a more comfortable blood donation process.
Gulf Coast Regional Blood Center adopts OrSense’s NBM-200 to improve donor comfort and measurement accuracy.
The Red Cross has a new prick-free method to test hemoglobin levels, improving donor experience.
Hoxworth Blood Center adopted OrSense’s NBM-200 device to enhance donor comfort by eliminating finger pricks.
Cedars-Sinai Blood Donor Services implemented OrSense’s NBM-200 device to replace traditional finger pricks.
The blood bank utilizes OrSense’s NBM-200 device to streamline donations and reduce discomfort.
LifeServe Blood Center introduces OrSense’s NBM-200 for a more comfortable blood donation process.
Gulf Coast Regional Blood Center adopts OrSense’s NBM-200 to improve donor comfort and measurement accuracy.